Cargando…
Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines
BACKGROUND -: The F11 Receptor (F11R; aka JAM-A, JAM-1) is a cell adhesion protein present constitutively on the membrane surface of circulating platelets and within tight junctions of endothelial cells (ECs). Previous reports demonstrated that exposure of ECs to pro-inflammatory cytokines causes in...
Autores principales: | Azari, Bani M, Marmur, Jonathan D, Salifu, Moro O, Ehrlich, Yigal H, Kornecki, Elizabeth, Babinska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142510/ https://www.ncbi.nlm.nih.gov/pubmed/21703019 http://dx.doi.org/10.1186/1479-5876-9-98 |
Ejemplares similares
-
In vivo data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice
por: Babinska, Anna, et al.
Publicado: (2020) -
Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment
por: Bednarek, Radoslaw, et al.
Publicado: (2019) -
Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
por: Bednarek, Radosław, et al.
Publicado: (2023) -
Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974) -
The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression
por: Czubak-Prowizor, Kamila, et al.
Publicado: (2021)